Elizabeth Hubert, APRN, explains how to treat patients receiving luspatercept for low-risk myelodysplastic syndromes.
Frontline LR-MDS Management: Strategies for Treatment Durability, Dosing, and Sequencing
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Oral Azacitidine Yields Similar PK to Subcutaneous Azacitidine in MDS/CMML
2
Progression Occurs Early in R/R LBCL Treated With Epcoritamab, Glofitamab
3
Frontline Axi-Cel CR Linked With Improved Survival in High-Risk LBCL
4
Pembrolizumab Plus RT Ups T-Cell Infiltration in Early Breast Cancer
5
